IL-1β is one of the first pro-inflammatory cytokines abnormally increased in the development of MPN and CML in mice (156), and clinically, such elevated levels of IL-1β in CML patients have been associated with poor prognosis (157). Here, IL1B is linked to myeloproliferative neoplasm.